Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

The Multichannel Masters – the story so far

Since we introduced Vendit and throughout its development into Trustrack, our dedicated Multichannel team have consistently, compliantly and digitally delivered for all our clients at Congresses, events and for their...

Healthcare Media Europe – HME Ltd

- PMLiVE

Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

The next generation of relationship holders will offer highly personalised services

Using contextual moments in marketing

Marketers talk about giving the right message to the right consumer at the right time as a key factor for any campaign. This has become even more refined and targeted...

Page & Page Health

- PMLiVE

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab’s OX40 candidate

The latest from pharma, biotech and healthcare

- PMLiVE

Alnylam’s amyloidosis drug heads latest crop of CHMP approvals

Three new biosimilars also gets the green light

Translating data to create a meaningful story

Embracing data to create numerous possibilities

- PMLiVE

What can pharma learn from the charity sector?

Collaborating with the third sector could lead to better patient support

Successful brands tell stories

Creating a strong brand story is the first step in developing a successful pharma brand. Here, Head of Insight Martine Leroy and Jocelyn Coutinho reveal the tools and techniques they...

Blue Latitude Health

- PMLiVE

Keytruda is first I-O drug cleared for melanoma in China

Company chasing rival BMS in world's biggest market

- PMLiVE

Amgen’s R&D chief Sean Harper retires to seek biotech post

Adds to trend in senior leaders

- PMLiVE

Nanobiotix signs €40m deal with the EIB

loan to fund innovative nanomedicine platform

- PMLiVE

Bluebird’s first gene therapy gets European fast track

For once, Europe set for approval and launch ahead of US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links